Certified by Founder Lodge
Wellington Management
United States - Boston, Massachusetts
INVESTOR
1 Disclosed Funding Rounds $238,000,000
135 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
-
Website
https://www.wellington.com/en/about-us/why-wellington-management
- Contact
- Social Links
For almost 100 years, we have chosen to do things differently, including the way we structure our ownership model, organization, and investment platform. Critically, we know that the best inv
| Company | Date | Round | Raised |
|---|---|---|---|
 Omada Health |
February, 23 ,2022 | Series E | $192,000,000 |
 CARGO Therapeutics |
March, 06 ,2023 | Series A | $200,000,000 |
 Clerkie |
April, 19 ,2023 | Series A | $33,000,000 |
 HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
 Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
 SeatGeek |
September, 01 ,2022 | Series E | $238,000,000 |
 Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
 Xepelin |
May, 05 ,2022 | Series B | $111,000,000 |
 Saluda Medical |
April, 17 ,2023 | Unknown | $150,000,000 |
 AMP Robotics |
May, 10 ,2023 | Series C | $99,000,000 |
 SPAN |
March, 22 ,2022 | Series B | $90,000,000 |
 Creditas |
January, 25 ,2022 | Series F | $260,000,000 |
 FalconX |
June, 22 ,2022 | Series D | $150,000,000 |
 Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
 Orennia |
July, 12 ,2023 | Series B | $25,000,000 |
| CARGO Therapeutics |
March, 06 ,2023 | Series A | $200,000,000 |
 Arcadia |
May, 10 ,2022 | Series E | $200,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| Omada Health |
February, 23 ,2022 | Series E | $192,000,000 |
| Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
| Clerkie |
April, 19 ,2023 | Series A | $33,000,000 |
 Asher Biotherapeutics |
April, 17 ,2024 | Series C | $55,000,000 |
| Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
| SPAN |
March, 22 ,2022 | Series B | $90,000,000 |
| Xepelin |
May, 05 ,2022 | Series B | $111,000,000 |
| Saluda Medical |
April, 17 ,2023 | Unknown | $150,000,000 |
| AMP Robotics |
May, 10 ,2023 | Series C | $99,000,000 |
| Creditas |
January, 25 ,2022 | Series F | $260,000,000 |
| Orennia |
July, 12 ,2023 | Series B | $25,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
 Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| CARGO Therapeutics |
March, 06 ,2023 | Series A | $200,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| Omada Health |
February, 23 ,2022 | Series E | $192,000,000 |
| Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
| Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
| Asher Biotherapeutics |
April, 17 ,2024 | Series C | $55,000,000 |
| Clerkie |
April, 19 ,2023 | Series A | $33,000,000 |
| SPAN |
March, 22 ,2022 | Series B | $90,000,000 |
| Creditas |
January, 25 ,2022 | Series F | $260,000,000 |
| Saluda Medical |
April, 17 ,2023 | Unknown | $150,000,000 |
 AssetWatch® |
May, 21 ,2024 | Series B | $38,000,000 |
| Orennia |
July, 12 ,2023 | Series B | $25,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| AMP Robotics |
May, 10 ,2023 | Series C | $99,000,000 |
| Omada Health |
February, 23 ,2022 | Series E | $192,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
 GrayMatter Robotics |
June, 21 ,2024 | Series D | $45,000,000 |
| Clerkie |
April, 19 ,2023 | Series A | $33,000,000 |
| Asher Biotherapeutics |
April, 17 ,2024 | Series C | $55,000,000 |
| Creditas |
January, 25 ,2022 | Series F | $260,000,000 |
| Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
| AssetWatch® |
May, 21 ,2024 | Series B | $38,000,000 |
| Saluda Medical |
April, 17 ,2023 | Unknown | $150,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
 Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| AMP Robotics |
May, 10 ,2023 | Series C | $99,000,000 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| HeartFlow, Inc |
April, 07 ,2023 | Series F | $215,000,000 |
| Orennia |
July, 12 ,2023 | Series B | $25,000,000 |
| GrayMatter Robotics |
June, 21 ,2024 | Series D | $45,000,000 |
| Clerkie |
April, 19 ,2023 | Series A | $33,000,000 |
| Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
| Asher Biotherapeutics |
April, 17 ,2024 | Series C | $55,000,000 |
| AssetWatch® |
May, 21 ,2024 | Series B | $38,000,000 |
| Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
| Saluda Medical |
April, 17 ,2023 | Unknown | $150,000,000 |
| AMP Robotics |
May, 10 ,2023 | Series C | $99,000,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| Asher Biotherapeutics |
April, 17 ,2024 | Series C | $55,000,000 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| GrayMatter Robotics |
June, 21 ,2024 | Series D | $45,000,000 |
| Orennia |
July, 12 ,2023 | Series B | $25,000,000 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| Clerkie |
April, 19 ,2023 | Series A | $33,000,000 |
| Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
| Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
| AssetWatch® |
May, 21 ,2024 | Series B | $38,000,000 |
| AssetWatch® |
May, 21 ,2024 | Series B | $38,000,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
| GrayMatter Robotics |
June, 21 ,2024 | Series D | $45,000,000 |
| AMP Robotics |
May, 10 ,2023 | Series C | $99,000,000 |
| Orennia |
July, 12 ,2023 | Series B | $25,000,000 |
| Asher Biotherapeutics |
April, 17 ,2024 | Series C | $55,000,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| GrayMatter Robotics |
June, 21 ,2024 | Series D | $45,000,000 |
| Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
 Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
| Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
| AssetWatch® |
May, 21 ,2024 | Series B | $38,000,000 |
 Mindset |
August, 21 ,2024 | Unknown | $1,300,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| Asher Biotherapeutics |
April, 17 ,2024 | Series C | $55,000,000 |
| GrayMatter Robotics |
June, 21 ,2024 | Series D | $45,000,000 |
 Trace Machina |
August, 23 ,2024 | Seed | $4,700,000 |
| Orennia |
July, 12 ,2023 | Series B | $25,000,000 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
 Metsera |
November, 14 ,2024 | Series B | $215,000,000 |
| Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
| AssetWatch® |
May, 21 ,2024 | Series B | $38,000,000 |
| Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
| GrayMatter Robotics |
June, 21 ,2024 | Series D | $45,000,000 |
| Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
| Mindset |
August, 21 ,2024 | Unknown | $1,300,000 |
| Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
| Asher Biotherapeutics |
April, 17 ,2024 | Series C | $55,000,000 |
| Mindset |
August, 21 ,2024 | Unknown | $1,300,000 |
| Trace Machina |
August, 23 ,2024 | Seed | $4,700,000 |
| Trace Machina |
August, 23 ,2024 | Seed | $4,700,000 |
| Bluejay Therapeutics |
May, 10 ,2024 | Series C | $182,000,000 |
| Metsera |
November, 14 ,2024 | Series B | $215,000,000 |
| Metsera |
November, 14 ,2024 | Series B | $215,000,000 |
 Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| AssetWatch® |
May, 21 ,2024 | Series B | $38,000,000 |
 Quince |
January, 29 ,2025 | Series C | $120,000,000 |
| GrayMatter Robotics |
June, 21 ,2024 | Series D | $45,000,000 |
 Tubulis GmbH |
October, 16 ,2025 | Series C | $359,197,300 |
| Element Biosciences |
July, 12 ,2024 | Series D | $277,000,000 |
 Cactus |
November, 06 ,2025 | Seed | $7,000,000 |
| Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
| Mindset |
August, 21 ,2024 | Unknown | $1,300,000 |
| Trace Machina |
August, 23 ,2024 | Seed | $4,700,000 |
| Metsera |
November, 14 ,2024 | Series B | $215,000,000 |
| Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| Quince |
January, 29 ,2025 | Series C | $120,000,000 |
| Tubulis GmbH |
October, 16 ,2025 | Series C | $359,197,300 |
| Cactus |
November, 06 ,2025 | Seed | $7,000,000 |
dezerv.
Kristal.AI
Finary
Savart
Lucky Energy | $25,000,000 | (Nov 13, 2025)
BoomPop | $41,000,000 | (Nov 13, 2025)
Vend Park | $17,500,000 | (Nov 13, 2025)
GC AI | $60,000,000 | (Nov 13, 2025)
Modulight Biotherapeutics | $12,000,000 | (Nov 13, 2025)
